Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | application note | ![]() |
||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Cohen et al., Biochim. et Biophysica Acta, 2013, 1833: 1104–1113, doi.org/10.1016/j.bbamcr.2012.12.021 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. M. Giudetti et al., BBA, 2020, 1865, doi.org/10.1016/j.bbalip.2020.158805 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Pesarchuk, 2016, Dissertation, Universtity of Vancouver | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | D. Marotta, PhD Thesis, 2015, University College London | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. J. Choi et al., Cancer Res., Apr 2007; 67: 3654 - 3662 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Pagano et al., 2014, US 8,778,905 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C. Benincá et al., J. Med. Genet., 2021, 58: 155–167, doi:10.1136/jmedgenet-2020-106861 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | L. Jennelle et al., J. Biol. Chem., Oct 2014; 289: 28870 - 28884. | ||
HeLa-229 |
Human cervix adenocarcinoma cell line (derivat of HeLa) | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | D. Kaul et al., Blood Cells, Molecules and Diseases, 2015, 55: 89-93, doi.org/10.1016/j.bcmd.2015.05.001 | |||
HeLa-DR-13–9 |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | B. Haynesa et al., Biochim Biophys Acta Mol Basis Dis., 2020,1866(1): 165561, doi:10.1016/j.bbadis | Link | ||
HeLa-eGFP |
Human cervix adenocarcinoma cell line, stably expressing eGFP (derivat of HeLa) | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | P. del Pino et al., Nano Lett, Oct 2010; 10(10): 3914-21 | |||
HeLa-fLuc |
Human cervix adenocarcinoma cell line, stably expressing Firefly-Luciferase (derivat of HeLa) | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | P. del Pino et al., Nano Lett, Oct 2010; 10(10): 3914-21 | |||
HEp-2 |
Human carcinoma cell line (HeLa contaminant) | ATCC CCL-23 | Human | unknown | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | H. Chi et al., Lin Chuang Er Bi Yan Hou Ke Za Zhi, Nov 2005; 19(21): 992-5 | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Wedeken et al., J. Biol. Chem., Dec 2011; 286: 42855 - 42862. | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | V. Le Fourn et al., Cell. Mol. Life Sci., 2013, 70: 1985-2002, DOI: https://doi.org/10.1007/s00018-012-1236-6 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. J. Choi et al., Cancer Res., Apr 2007; 67: 3654 - 3662 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. I. Koukourakis et al., Investigational New Drugs, 2018, doi.org/10.1007/s10637-018-0566-0 | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Ullio et al., J. Lipid Res., Jun 2012; 53: 1134 - 1143 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | M.I. Koukourakis et al., Scientific Reports, 2016, 6:30986; DOI: 10.1038/srep30986 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | O. Pellerito et al., Mol. Pharmacol., May 2010; 77: 854 - 863 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. Prokesch et al., FASEB J., 2017, 31: 732-742 | Link | |
HepG2.2.15 |
Human hepatoma cell line expressing complete HBV genome | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | C. Zhu et al., Zhonghua Yi Xue Za Zhi, Sep 2005; 85(35): 2503-6 | |||
HepG2.2.15 |
Human hepatoma cell line expressing complete HBV genome | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | C. Zhu et al., Zhonghua Gan Zang Bing Za Zhi, Sep 2004; 12(9): 522-5 | |||
hESC-RPE |
Human embryonic stem cell-derived retinal pigment epithelium cells | Human | sensory organs | primary cell | siRNA | RNA-Interference | Metafectene PRO | publication | E. Ramsay et al., Pharmaceutics, 2020, 12(7): 667, doi: 10.3390/pharmaceutics12070667 | Link |